» Articles » PMID: 31772167

Both Fallopian Tube and Ovarian Surface Epithelium Are Cells-of-origin for High-grade Serous Ovarian Carcinoma

Overview
Journal Nat Commun
Specialty Biology
Date 2019 Nov 28
PMID 31772167
Citations 119
Authors
Affiliations
Soon will be listed here.
Abstract

The cell-of-origin of high grade serous ovarian carcinoma (HGSOC) remains controversial, with fallopian tube epithelium (FTE) and ovarian surface epithelium (OSE) both considered candidates. Here, by using genetically engineered mouse models and organoids, we assessed the tumor-forming properties of FTE and OSE harboring the same oncogenic abnormalities. Combined RB family inactivation and Tp53 mutation in Pax8 + FTE caused Serous Tubal Intraepithelial Carcinoma (STIC), which metastasized rapidly to the ovarian surface. These events were recapitulated by orthotopic injection of mutant FTE organoids. Engineering the same genetic lesions into Lgr5 + OSE or OSE-derived organoids also caused metastatic HGSOC, although with longer latency and lower penetrance. FTE- and OSE-derived tumors had distinct transcriptomes, and comparative transcriptomics and genomics suggest that human HGSOC arises from both cell types. Finally, FTE- and OSE-derived organoids exhibited differential chemosensitivity. Our results comport with a dualistic origin for HGSOC and suggest that the cell-of-origin might influence therapeutic response.

Citing Articles

Exploring the characteristics of immortalized human ovarian surface epithelial cell lines.

Shin H, Yang W, Kim J, Chang H, Yoo J, Choi W Heliyon. 2025; 11(4):e42539.

PMID: 40034272 PMC: 11874562. DOI: 10.1016/j.heliyon.2025.e42539.


IER5 Promotes Ovarian Cancer Cell Proliferation and Peritoneal Dissemination.

Krishnaraj J, Ueno S, Nakamura M, Tabata Y, Yamamoto T, Asano Y Cancers (Basel). 2025; 17(4).

PMID: 40002205 PMC: 11853144. DOI: 10.3390/cancers17040610.


Aggressive Serous Carcinomas of the Female Reproductive Tract: Cancer-Prone Cell States and Genetic Drivers.

Phuong D, Pirtz M, Ralston C, Cosgrove B, Schimenti J, Flesken-Nikitin A Cancers (Basel). 2025; 17(4).

PMID: 40002199 PMC: 11852459. DOI: 10.3390/cancers17040604.


Molecular and functional profiling of primary normal ovarian cells defines insights into cancer development and drug responses.

Piki E, Dini A, Rantanen F, Bentz F, Paavolainen L, Barker H Mol Ther Oncol. 2024; 32(4):200903.

PMID: 39634630 PMC: 11616607. DOI: 10.1016/j.omton.2024.200903.


Organoids research progress in gynecological cancers: a bibliometric analysis.

He B, Ma H, Yu H, Li D, Zhang L, Wang J Front Oncol. 2024; 14:1484074.

PMID: 39529835 PMC: 11552305. DOI: 10.3389/fonc.2024.1484074.


References
1.
Garfin P, Min D, Bryson J, Serwold T, Edris B, Blackburn C . Inactivation of the RB family prevents thymus involution and promotes thymic function by direct control of Foxn1 expression. J Exp Med. 2013; 210(6):1087-97. PMC: 3674705. DOI: 10.1084/jem.20121716. View

2.
Bowtell D, Bohm S, Ahmed A, Aspuria P, Bast Jr R, Beral V . Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer. 2015; 15(11):668-79. PMC: 4892184. DOI: 10.1038/nrc4019. View

3.
Kuhn E, Kurman R, Vang R, Sehdev A, Han G, Soslow R . TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions. J Pathol. 2011; 226(3):421-6. PMC: 4782784. DOI: 10.1002/path.3023. View

4.
Gilks C, Irving J, Kobel M, Lee C, Singh N, Wilkinson N . Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas. Am J Surg Pathol. 2014; 39(3):357-64. DOI: 10.1097/PAS.0000000000000353. View

5.
Flesken-Nikitin A, Choi K, Eng J, Shmidt E, Nikitin A . Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium. Cancer Res. 2003; 63(13):3459-63. View